The maturation of murine bone marrow-derived dendritic cells by tumor lysate uptake in vitro is not essential for cancer immunotherapy

Cancer Biology and Therapy

Volumn 4, Issue 12, 2005, Pages 1331-1335

  Woo, Sung Chil ^a   Kim, Gi Young ^b   Lee, Chang Min ^a   Moon, Dong Oh ^a   Kim, Hyung Keun ^a   Lee, Tae Hyung ^a   Moon, Yu Seok ^a   Park, Nam Chul ^a   Yoon, Man Soo ^a   Lee, Kyu Sub ^a   Park, Yeong Min ^a  

^a Pusan National University School of Medicine   (South Korea)

^b Jeju National University   (South Korea)

Author keywords

Dendritic cells; IFN ; IL 12; MCA 102 fibrosarcoma; Tumor lysate

Indexed keywords

B7 ANTIGEN; CD86 ANTIGEN; INTERLEUKIN 12P70; LIPOPOLYSACCHARIDE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; BONE MARROW; CANCER IMMUNOTHERAPY; CELL FUNCTION; CELL LYSATE; CELL MATURATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; FIBROSARCOMA; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPE; IMMUNE RESPONSE; MOUSE; NONHUMAN; PHAGOCYTOSIS; PHENOTYPE; PROTEIN SECRETION; SPLEEN CELL; T LYMPHOCYTE; TUMOR IMMUNITY;

EID: 31144477763     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.4.12.2158     Document Type: Article

References (37)

1. Crowley M, Inaba K, Steinman RM, Dendritic cells are the principal cells in mouse spleen bearing immunogenic fragments of foreign proteins J Exp Med 1990; 172:383-6.
2. Steinman RM. The dendritic cell system and its role in immunogenicity. Ann Rev Immunol 1991; 9:271-96.
3. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998; 392:245-52.
4. Banchereau J, Briere F, Caux C, Davoust J, Lebecque S, Liu Y, Pulendran B, Palucka K. Immunobiology of dendritic cells. Annu Rev Immunol 2000; 18:767-811.
5. Celluzzi CM, Mayordomo JI, Storkus WJ, Lotze MT, Falo LD. Peptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunity. J Exp Med 1996; 183:283-7.
6. Miconnet I, Coste I, Beermann F, Haeuw JF, Cerottini JC, Bonnefoy JY, Romero P, Renno T. Cancer vaccine design: A novel bacterial adjuvant for peptide-specific CTL induction. J Immunol 2001; 166:4612-9.
7. Wang HY, Fu T, Wang G, Zeng G, Perry-Laller DM, Yang JC, Restifo NP, Hwu P, Wang RF. Induction of CD4(+) T cell-dependent antitumor immunity by TAT-mediated tumor antigen delivery into dendritic cells. J Clin Invest 2002; 109:1463-70.
8. Nestle FO, Aligagic S, Gilliet M, Sun Y, Grabbe S, Dummer R, Burg G, Schadendorf D. Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells. Murine dendritic cells pulsed with whole tumor lysates mediate potent antitumor immune responses in vitro and in vivo. Nat Med 1998; 4:328-32.
9. Fields RC, Shimizu K, Mule J. Murine dendritic cells pulsed with whole tumor lysates mediate potent antitumor immune responses in vitro and in vivo. J Pro Natl Acad Sci USA 1998; 95:9482-7.
10. Nishioka Y, Hirao M, Robbins PD, Lotze MT, Tahara H. Induction of systemic and therapeutic antitumor immunity using intratumoral injection of dendritic cells genetically modified to express interleukin 12. Cancer Res 1999; 59:4035-41.
11. Rodriguez-Calvillo M, Duarte M, Tirapu I, Berraondo P, Mazzolini G, Qian C, Prieto J, Melero I. Upregulation of natural killer cells functions underlies the efficacy of intratumorally injected dendritic cells engineered to produce interleukin-12. Exp Hematol 2002; 30:195-204.
12. Nouri-Shirazi M, Banchereau J, Bell D, Burkeholder S, Kraus ET, Davoust J, Palucka KA. Dendritic cells capture killed tumor cells and present their antigens to elicit tumor-specific immune responses. J Immunol 2000; 165:3797-803.
13. Sauter B, Albert ML, Francisco L, Larsson, M, Somersan S, Bhardwaj N. Consequences of cell death: Exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells. J Exp Med 2000; 191:423-34.
14. Kotera Y, Shimizu K, Mele J. Comparative analysis of necrotic and apoptotic tumor cells as a source of antigen(s) in dendritic cell-based immunization. J Cancer Res 2001; 61:8105-9.
15. Kurts C, Miller JFAP, Subramantiam RM, Carbone FR, Heath WR. Major histocompatibility complex class I-restricted cross-presentation is biased towards high dose antigens and those released during cellular destruction. J Exp Med 1998; 188:409-14.
16. Kurts C, Heath WR, Kosaka H, Miller JAFP, Carbone FR. The peripheral deletion of autoreactive CD8+ T cells induced by cross-presentation of self-antigens involves signaling through CD95 (Fas, Apo-1). J Exp Med 1998; 188:415-20.
17. Ronchetti A, Rovere P, Iezzi G., Galati G, Heltai S, Protti MP, Garancini MP, Manfiedi AA. Immunogenicity of apoptotic cells in vivo: Role of antigen load, antigen-presenting cells, and cytokines. J Immunol 1999; 163:130-6.
18. Herr W, Ranieri E, Olson W, Zarour H, Gesualdo L, Storkus WJ. Mature dendritic cells pulsed with freeze-thaw cell lysates define an effective in vitro vaccine designed to elicit EBV-specific CD4(+) and CD8(+) T lymphocyte responses. Blood 2000; 96:1857-64.
19. Kim GY, Oh WK, Shin BC, Shin YI, Park YC, Ahn SC, Lee JD, Bae YS, Kwak JY, Park YM. Proteoglycan isolated from Phellinus linteus inhibits tumor growth through mechanisms leading to an activation of CD11c+CD8+ DC and type I helper T cell-dominant immune state. FEBS Lett 2004; 576:391-400.
20. Geraghty PJ, Johnson TM, Sondak VK, Chang AE. Surgical therapy of primary cutaneous melanoma. Semin Surg Oncol 1996; 12:386-93.
21. Inaba K, Inaba M, Romani N, Aya H, Deguchi M, Ikehara S, Muramatsu S, Steinman RM. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J Exp Med 1992; 176:1693-702
22. Schnurr M, Galambos P, Scholz C, Then F, Dauer M, Endres S, Eifler A. Tumor cell lysate-pulsed human dendritic cells induce a T-cell response against pancreatic carcinoma cells: An in vitro model for the assessment of tumor vaccines. Cancer Res 2001; 61:6445-50.
23. Kodaira Y, Ikuta K, Tanaka S, Yolomuro K. Antigen-driven clonal accumulation of peritoneal gammadelta T cells in vivo. Immunol Invest 1999; 28:137-48.
24. Trinchieri G. Proinflammatory and immunoregulatory functions of interleukin-12. Int Rev Immunol 1998; 16:365-96.
25. Hiramoto JS, Tsung K, Bedolli M, Norton JA, Hirose RJ, Surg. Antitumor immunity induced by dendritic cell-based vaccination is dependent on interferon-gamma and interleukin-12. Cancer Res 2004; 116:64-9.
26. Austyn JM, Kupie-Weglinski JW, Hankins DF, Morris PJ. Migration patterns of dendritic cells in the mouse. Homing to T cell-dependent areas of spleen, and binding within marginal zone. J Exp Med 1988; 167:646-51.
27. Rock KL. A new foreign policy: MHC class I molecules monitor the outside world. Immunol Today 1996; 17:131-7.
28. Okada N, Tsujino M, Hagiwara Y, Tada A, Tamura Y, Mori K, Saito T, Nakagawa S, Mayumi T, Fujita T, Yamamoto A. Administration route-dependent vaccine efficiency of murine dendritic cells pulsed with antigens. Cancer Res 2001; 84:1564-70.
29. Shen Z, Reznikoff G, Dranoff G, Rock KL. Cloned dendritic cells can present exogenous antigens on both MHC class I and class II molecules. J Immunol 1997; 158:2723-30.
30. Norbury CC, Chambers BJ, Prescott AR, Ljunggren HG, Watts C. Constitutive macropinocytosis allows TAP-dependent major histocompatibility complex class I presentation of exogenous soluble antigen by bone marrow-derived dendritic cells. Eur J Immunol 1997; 27:280-8.
31. Rodriguez A, Regnault A, Kleijmeer M, Ricciardi CP, Amigorena S. Selective transport of internalized antigens to the cytosol for MHC class I presentation in dendritic cells. Nat Cell Biol 1999; 1:362-8.
32. Machy P, Serre K, Leserman L. Class I-restricted presentation of exogenous antigen acquired by Fcgamma receptor-mediated endocytosis is regulated in dendritic cells. Eur J Immunol 2000; 30:848-57.
33. Wan Y, Bramson. Role of dendritic cell-derived cytokines in immune regulation. J Curr Pharm Des 2001; 7:977-92.
34. Melero I, Duarte M, Ruiz J, Sangro B, Galofre J, Mazzolini G, Bustos M, Qian C. Prieto Intratumoral injection of bone-marrow derived dendritic cells engineered to produce interleukin-12 induces complete regression of established murine transplantable colon adenocarcinomas. J Gene Ther 1999; 6:1779-84.
35. Brand U, Bellinghausen I, Enk AH, Jonuleit H, Becker D, Knop J, Saloga J. Influence of extracellular matrix proteins on the development of cultured human dendritic cells. Eur J Immunol 1998; 28:1673-80.
36. Lu L, Woo L, Rao AS, Li Y, Watkins SC, Qian S, Starzl TE, Demetris AJ, Thomson AW. Propagation of dendritic cell progenitors from normal mouse liver using granulocte/macrophage colony-stimulating factor and their maturational development in the presence of type-1 collagen. J Exp Med 1994; 179:1823-34.
37. Mahnke K, Bhardwaj RS, Luger TA, Schwarz T, Grabbe S. Interaction of murine dendritic cells with collagen up-regulates allostimulatory capacity, surface expression of heat stable antigen, and release of cytokines. J Leukoc Biol 1996; 60:465-72.